Competitor News, Product Updates, Synthetic Data

Replica Analytics’ new estimator uses synthetic data for more reliable evaluation of re-identification risk in datasets

OTTAWA, ON, July 19, 2022 /PRNewswire/ – Replica Analytics, an Aetion company, has unveiled a novel approach to use synthetic data for a more accurate assessment of re-identification risks in datasets, to better manage privacy risks and enable greater data sharing in healthcare and other sectors. “Re-identification risk is the probability that an adversary will correctly…

Competitor News, Product Updates

QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases

QIAGEN Clinical Insights platform growing at over 35% annually, or 700,000 additional cases, and recently breaking through three million cases analyzed and reported Total number of analyzed and reported patient cases using QCI five times higher than other commercial offerings Unique Augmented Molecular Intelligence approach provides customers with the ability…

AI, Competitor News, HR

Mendel Appoints Two Executive Leaders to Support Expansion in Healthcare Market

Sailu Challapalli named as Chief Product Officer and Hylton Kalvaria named as Chief Commercial Officer July 19, 2022 09:00 AM Eastern Daylight Time SAN JOSE, Calif.–(BUSINESS WIRE)–Mendel, the leading clinical artificial intelligence and natural language processing platform, today announced the expansion of its leadership team with two key C-suite hires: Sailu…

Collaborations, Competitor News

Datavant and Parkinson’s Foundation Collaborate to Drive Insights into Parkinson’s Disease Research

NEW YORK and SAN FRANCISCO, July 19, 2022 (GLOBE NEWSWIRE) — Datavant, the leader in helping organizations securely connect health data, and the Parkinson’s Foundation, a national nonprofit dedicated to making life better for people living with Parkinson’s disease (PD), announced a partnership that will further build out PD patient…

Competitor News, Product Updates, Synthetic Data

Replica Analytics’ new estimator uses synthetic data for more reliable evaluation of re-identification risk in datasets

OTTAWA, ON, July 19, 2022 /PRNewswire/ – Replica Analytics, an Aetion company, has unveiled a novel approach to use synthetic data for a more accurate assessment of re-identification risks in datasets, to better manage privacy risks and enable greater data sharing in healthcare and other sectors. “Re-identification risk is the probability that an adversary will correctly…

Industry News

Health Data Exchange Barriers Impede Widespread Interoperability

Office-based physicians said using multiple systems to enable exchange, data sharing within a network, and cross-vendor exchange are challenging health data exchange barriers.  By Sarai Rodriguez July 19, 2022 – Widespread interoperability among office-based physicians is lacking due to a number of health data exchange barriers, according to a recent ONC Data Brief. The report used…

Collaborations, Oncology, Partner and Collaborator News

Amazon launches cancer vaccine clinical trial in partnership with Fred Hutchinson

Amazon is developing cancer vaccines in collaboration with the Fred Hutchinson Cancer Research Center, and it recently launched an FDA-approved clinical trial. Amazon and Fred Hutchinson are looking to recruit 20 participants over the age of 18 for the early stage, or phase 1, trial, according to a filing on clinicaltrials.gov, a…

Competitor News, RWE Study

Verana Health Presents Geographic Atrophy and Diabetic Macular Edema Research at ASRS 2022 Annual Meeting

Research developed using Verana Health’s Ophthalmology Qdata™, quality real-world data stemming from the American Academy of Ophthalmology IRIS® Registry SAN FRANCISCO, July 18, 2022 /PRNewswire/ — Verana Health®—a digital health data company elevating quality in real-world data—delivered two podium presentations at the American Society of Retina Specialists (ASRS) 2022 Annual Meeting in New York City on…

AI, Collaborations, Competitor News, Data Partnership

Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

Novartis Pharmaceuticals Corporation to collaborate on development of new medical device software for earlier detection and intervention in cardiovascular disease July 13, 2022 08:47 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a multi-year strategic collaboration with Novartis…